These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5158138)

  • 21. [Immunological parameters in uremic patients under hemodialysis].
    Pigareva NV; Polenova IM
    Klin Med (Mosk); 1981 Mar; 59(3):75-9. PubMed ID: 7265837
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Behavior of uremic hyperlipemia and disturbances of glucose tolerance under chronic intermittent hemodialysis treatment].
    Hübner W; Diemer A; Freiberg J
    Med Welt; 1972 Oct; 23(41):1415-7. PubMed ID: 4648587
    [No Abstract]   [Full Text] [Related]  

  • 24. Dialysis disequilibrium syndrome and other treatment complications of extreme uremia: a rare occurrence yet not vanished.
    Lopez-Almaraz E; Correa-Rotter R
    Hemodial Int; 2008 Jul; 12(3):301-6. PubMed ID: 18638082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Extracellular and intracellular water-electrolyte changes and acid-base equilibrium changes after extracorporeal hemodialysis in chronic uremic patients].
    Acquarone N; Bertocchi I; De Ferrari G; Gurreri G; Menozzi PG; Tizianello A
    Minerva Nefrol; 1970; 17(6):190-7. PubMed ID: 5516054
    [No Abstract]   [Full Text] [Related]  

  • 26. [A simplified hemodialysis system for clinical and home dialysis].
    Strauch M; Esmond WG; von Henning GE; Lewitinn A
    Verh Dtsch Ges Inn Med; 1967; 73():999-1002. PubMed ID: 5591871
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduced postheparin plasma diamine oxidase activity in patients with chronic renal failure.
    Stein J; Scheuermann EH; Yazdi R; Lembcke B; Caspary WF
    Z Gastroenterol; 1994 Apr; 32(4):236-9. PubMed ID: 8017098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The excretion of ascorbic acid and its metabolites in uremia and hemodialysis].
    Bakaev VV; Efremov AV
    Patol Fiziol Eksp Ter; 2000; (2):22-4. PubMed ID: 10846906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transketolase activity in red blood cells in chronic uremia.
    Kopple JD; Dirige OV; Jacob M; Wang M; Swendseid ME
    Trans Am Soc Artif Intern Organs; 1972; 18(0):250-6, 266. PubMed ID: 4610963
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of terminal-stage uremia by substitution dialysis methods in France in December 1981].
    Jacobs C; Patte R
    Nephrologie; 1983; 4(2):64-8. PubMed ID: 6877480
    [No Abstract]   [Full Text] [Related]  

  • 31. [Problems of perodic hemodialysis treatment in patients with chronic renal failure].
    Migone L
    Munch Med Wochenschr; 1969 Mar; 111(13):725-31. PubMed ID: 5818659
    [No Abstract]   [Full Text] [Related]  

  • 32. [Arteriovenous fistula of the forearm for periodic hemodialysis in patients with terminal chronic uremia].
    Bonomini V; Martelli A; Mioli V; Reggiani A
    Minerva Nefrol; 1968; 15(4):287-9. PubMed ID: 5745821
    [No Abstract]   [Full Text] [Related]  

  • 33. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis.
    Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V
    Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Catalytic activity of transketolase in erythrocytes in chronic kidney failure].
    Mydlík M; Derzsiová K; Takác M; Szabó T; Dandár V
    Vnitr Lek; 1984 Jul; 30(7):642-8. PubMed ID: 6495664
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hemodialysis in the treatment of chronic kidney failure].
    Krylov NL; Kozlechkov IuA
    Voen Med Zh; 1981 Aug; (8):35-9. PubMed ID: 7293043
    [No Abstract]   [Full Text] [Related]  

  • 36. [Problems of periodic hemodialysis in treatment of chronic renal insufficiency].
    Migone L
    Minerva Med; 1968 Dec; 59(100):5553-63. PubMed ID: 5707464
    [No Abstract]   [Full Text] [Related]  

  • 37. Blood levels of middle molecules and their effects on motor nerve conduction velocity.
    Botella J; Gea T; Sanz-Guajardo D; Criado M; Torres MT; Guardiola J
    Artif Organs; 1981; 4 Suppl():151-5. PubMed ID: 7295082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guanidinosuccinic acid and transketolase.
    Stein IM
    N Engl J Med; 1971 Sep; 285(11):637. PubMed ID: 5563971
    [No Abstract]   [Full Text] [Related]  

  • 39. [Latent uremic neuropathy. Electromyographic and electroencephalographic observations in chronic renal patients treated with conservative therapy and with peritoneal dialysis].
    Caruso G; Spadetta V; Labianca O; Mastrangelo F; Amerio A
    Riv Patol Nerv Ment; 1968 Aug; 89(4):348-72. PubMed ID: 5760426
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pulmonary diffusion capacity in uremic patients undergoing maintenance hemodialytic treatment].
    Casucci G; Marchesi N; Buoncristiani U; Timio M; Sorbini CA
    Minerva Nefrol; 1971; 18(3):186-8. PubMed ID: 5115764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.